|
rdfs:label
|
"Ledipasvir"@de
"Ledipasvir"@es
"Ledipasvir"@fr
"Ledipasvir"@it
"Ledipasvir"@ro
"Ledipasvir"@sh
"Ledipasvir"@sr
"Ledipasvir"@tr
"Ledipasvir"@vi
"ledipasviiri"@fi
"ledipasvir"@en
"ledipasvir"@nn
"ledipasvir"@pt
"ledipasvir"@sl
"ledypaswir"@pl
"λεντιπασβίρη"@el
"Ледипасвир"@ru
"ледіпасвір"@uk
"لدیپاسویر"@fa
"ليديباسفير"@ar
"レジパスビル"@ja
"雷迪帕韦"@zh
"레디파스비르"@ko
|
|
skos:altLabel
|
"GS 5885"@en
|
|
"GS-5885"@en
|
|
"GS5885"@en
|
|
"WHO 9796"@en
|
|
schema:description
|
"cheemesch Verbindung"@lb
"chemical compound"@en
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"compositum chemicum"@la
"compost químic"@ca
"composto chimico"@it
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"composé chimique"@fr
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"kemia kombinaĵo"@eo
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kemična spojina"@sl
"kimyasal bileşik"@tr
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"senyawa kimia"@id
"związek chemiczny, lek"@pl
"ķīmisks savienojums"@lv
"χημική ένωση"@el
"химическое соединение"@ru
"хімічна сполука"@uk
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"രാസസംയുക്തം"@ml
"药物"@zh
|
|
schema:dateModified
|
"2026-06-19T15:44:40+00:00"^^xsd:dateTime
|
|
schema:version
|
2507959200
|
|
wikibase:identifiers
|
27
|
|
wikibase:sitelinks
|
21
|
|
wikibase:statements
|
46
|
|
p:P10283
|
wd:statement/Q15409409-C3766187-1182-4AD9-A994-E14B128BF44B
|
|
p:P11089
|
wd:statement/Q15409409-225F8057-C2AF-4840-814B-5F41B6FE0D61
|
|
p:P11198
|
wd:statement/Q15409409-82E861CB-F537-468F-A353-143B08C7D731
|
|
p:P11199
|
wd:statement/Q15409409-A120DCD2-D2AF-442E-9171-2B98283BCD75
|
|
p:P117
|
wd:statement/Q15409409-979e0556-4c4f-b1af-3505-2048b876faf3
|
|
p:P1579
|
wd:statement/Q15409409-282FB36E-3E36-4A11-941F-F323A7D8EB30
|
|
p:P2017
|
wd:statement/Q15409409-5AEBA674-78AC-4532-AEE1-C9092F7E57E0
|
|
p:P2067
|
wd:statement/Q15409409-83BC095C-0A36-4BFA-BA70-03D40C92E999
|
|
p:P2115
|
wd:statement/Q15409409-7D16DF41-8977-4A1B-8C45-FA148A4D00E7
|
|
p:P2175
|
wd:statement/Q15409409-A80F3E95-B647-4B33-8F13-816EC3F90566
|
|
p:P231
|
wd:statement/Q15409409-1696D557-2D08-4342-9E62-14F75936FB1D
|
|
p:P233
|
wd:statement/Q15409409-D66F3E76-7D8E-483B-8278-F96EF31969A7
|
|
p:P234
|
wd:statement/Q15409409-B2D16855-E667-49F3-A745-1E32B97727BF
|
|
p:P235
|
wd:statement/Q15409409-3C8770CC-527B-4C83-B1EF-A323DF0FF168
|
|
p:P274
|
wd:statement/Q15409409-825C6523-0F22-4E11-8872-5577BBB8F427
|
|
p:P279
|
wd:statement/Q15409409-06BB499E-87EA-4F35-A73D-5E62FD424547
|
|
wd:statement/Q15409409-169E545C-7FB6-49AF-9428-321689DB0651
|
|
p:P2868
|
wd:statement/Q15409409-04CA5FAE-5051-47AC-A457-91C4142AD031
|
|
wd:statement/Q15409409-44AF8F09-52EB-48BE-8B1F-E5DBFC4D4FDE
|
|
wd:statement/Q15409409-44F4D1DB-C3FE-4DDC-8957-5AFE79BC05F4
|
|
wd:statement/Q15409409-D1812A39-38E5-4F31-8249-33A659020CDA
|
|
wd:statement/Q15409409-E31C0812-55B9-401C-BF7B-6682D8146F83
|
|
p:P2877
|
wd:statement/Q15409409-89F6B535-7A48-485B-A74A-40A644719C79
|
|
wd:statement/Q15409409-95B0E123-A9C7-4CB1-9F3D-0F73C91F3E8F
|
|
p:P2892
|
wd:statement/Q15409409-4604C534-30F3-4868-A34C-A2FE781F22BA
|
|
p:P31
|
wd:statement/Q15409409-AD8969BA-C77D-4E70-9FC4-6994EB6437CF
|
|
p:P3117
|
wd:statement/Q15409409-C840A3B4-4D8A-40B1-9CF9-CC38D03351D1
|
|
p:P3345
|
wd:statement/Q15409409-4B801E29-4ABB-49D3-8E0F-D149BE06FC46
|
|
p:P366
|
wd:statement/Q15409409-1058E474-E8E8-472C-8007-D0A411760C81
|
|
p:P373
|
wd:statement/Q15409409-BF010EE8-E6DF-406C-B1A0-E8A62E7D9C07
|
|
p:P486
|
wd:statement/Q15409409-76FDF062-FF54-4E8F-A364-2AB703B2960B
|
|
p:P592
|
wd:statement/Q15409409-92D74E25-FCE5-4745-B370-63D52BC28243
|
|
p:P595
|
wd:statement/Q15409409-499D0E5E-7D6E-459B-84D4-6F8854C87E1B
|
|
p:P6366
|
wd:statement/Q15409409-88079512-F5F7-4CBD-9336-E5D7A72DB1E7
|
|
p:P646
|
wd:statement/Q15409409-F3F40BB2-5F91-4707-A190-C0BD77012BD1
|
|
p:P652
|
wd:statement/Q15409409-859820F7-01F6-42F1-9FA0-8A24480B605B
|
|
p:P661
|
wd:statement/Q15409409-8B4E01A7-D613-4890-AEBE-D2F761BD017C
|
|
p:P662
|
wd:statement/Q15409409-10ACEF72-294C-4316-B85B-52A55271F7A3
|
|
p:P665
|
wd:statement/Q15409409-44AFB2B8-EC2A-4A9E-8895-BE274C932096
|
|
p:P683
|
wd:statement/Q15409409-1398420F-EC45-4036-9B12-E1982703A7C4
|
|
p:P715
|
wd:statement/Q15409409-6903B260-7BF5-4313-B45C-F53C62DEDC62
|
|
p:P769
|
wd:statement/Q15409409-6DDB8739-26D6-44C9-A828-3F7B6709CD60
|
|
wd:statement/Q15409409-F7C77D86-4731-44AE-AD3A-FE4BC697A52F
|
|
p:P8072
|
wd:statement/Q15409409-38D0B7AA-DD2D-4F44-87A7-1E0EBEFE08AB
|
|
p:P8494
|
wd:statement/Q15409409-A5354006-961E-4BFC-8BB4-86CB7B4027DC
|
|
p:P972
|
wd:statement/Q15409409-EF946C4E-FD67-406F-AA0A-2E1C5BA8033E
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000191095>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/C586541>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL2374220>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2775999097>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/29271894>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67505836>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D10442>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_85089>
|
|
wdt:P10283
|
"C2775999097"
|
|
wdt:P11089
|
"59192360"
|
|
wdt:P11198
|
"4899"
|
|
wdt:P11199
|
"PD009401"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Ledipasvir.svg>
|
|
wdt:P1579
|
"23926149"
|
|
wdt:P2017
|
"CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC"
|
|
wdt:P2067
|
888.413438^^xsd:decimal
|
|
wdt:P2115
|
"N0000191095"
|
|
wdt:P2175
|
hepatitis C
|
|
wdt:P231
|
"1256388-51-8"
|
|
wdt:P233
|
"CC(C)C(C(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)C9C1CCC(C1)N9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC"
|
|
wdt:P234
|
"InChI=1S/C49H54F2N8O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63)/t29-,30+,38-,39-,40-,41-/m0/s1"
|
|
wdt:P235
|
"VRTWBAAJJOHBQU-KMWAZVGDSA-N"
|
|
wdt:P274
|
"C₄₉H₅₄F₂N₈O₆"
|
|
wdt:P279
|
heterocyclic compound
|
|
carbocyclic compound
|
|
wdt:P2868
|
WHO essential medicines
|
|
antiviral agent
|
|
xenobiotic-transporting ATPase inhibitor
|
|
bactericide
|
|
antiviral drug
|
|
wdt:P2877
|
"15116943"
|
|
"2706494"
|
|
wdt:P2892
|
"C3851350"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID90154829"
|
|
wdt:P3345
|
"1591922"
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Ledipasvir"
|
|
wdt:P486
|
"C586541"
|
|
wdt:P592
|
"CHEMBL2374220"
|
|
wdt:P595
|
"11271"
|
|
wdt:P6366
|
"2775999097"
|
|
wdt:P646
|
"/m/0rffj1_"
|
|
wdt:P652
|
"013TE6E4WV"
|
|
wdt:P661
|
"29271894"
|
|
wdt:P662
|
"67505836"
|
|
wdt:P665
|
"D10442"
|
|
wdt:P683
|
"85089"
|
|
wdt:P715
|
"DB09027"
|
|
wdt:P769
|
rosuvastatin
|
|
wdt:P8072
|
"33903"
|
|
wdt:P8494
|
"DTXCID8077320"
|
|
wdt:P972
|
CAS COVID-19 Anti-Viral Candidate Compounds
|